Autopsy report · NCT05307172
Precision Medicine Approach to Unravel the Risk Factors for Renal, Cardiovascular, Ophthalmologic, Neurologic and Hepatic Complications of Metabolic Disorders
Cause of deathRegulatory or ethics
“No inclusion within 2 years of approval by CPP”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Sponsor
- Institut National de la Santé Et de la Recherche Médicale, France
- Sponsor type
- Government (non-US federal)
- Conditions
- Chronic Kidney Diseases; Diabetes; Obesity
- Participants
- 0
- Sites
- 1
- Countries
- France
Trials that died the same way
- Efficacy of Azithromycin-associated Hydroxychloroquine Therapy Given in General Practice in Early-stage Disease in COVID-19 Patients
“Regulatory approvals have not been obtained” - Opinions, Perceptions, & Thoughts of British Resident Doctors on Orthopaedics
“Study did not progress past approvals” - Influencing Wound Healing Through the Application of Hyaluronic Acid With Perfluorodecalin and Physalis Angulata Extract After Split Skin Removal From the Thigh - A Study in "Split Wound Design"
“no approval by CA” - Potassium Chloride in Out-of-hospital Cardiac Arrest Due to Refractory Ventricular Fibrillation
“As the inclusion period in the study has ended and regulatory authorizations have expired on 26/12/2023, with no inclusions conducted.” - Azacitidine in Treating Patients With Triple Negative Stage I-IV Invasive Breast Cancer That Can Be Removed By Surgery
“No accrual last 2 years”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.